Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom
    AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
    Release Date:
    Review Process: Pfizer Internal
    Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan
    Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-posit
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology United States Minor Outlying I
    OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic Malignancies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory Outcome
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Pfizer Internal
    Fellowship Internal Medicine Germany
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
    Release Date:
    Partner: American College of Emergency Physicians (ACEP)
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Hospital Benin, Congo, The Democratic Republic
    Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Management of Adults and Adolescents with Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Sickle Cell Disease Transition in Care
    Release Date:
    Partner: National Alliance of Sickle Cell Centers
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease USA
    2025 Rheumatology Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Invasive Mold Diseases (IMD) & Treatment Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
    Implementing Updated RSV Immunization Recommendations for Older Adults
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA